Oral BG-12 (Dimethyl Fumarate) Significantly Reduced Multiple Sclerosis (MS) Relapses and Disability Progression in Define Phase 3 Clinical Trial --240 mg of BG-12 Administered Either Twice or Three ...
A non-volatile, random access memory (RAM) technology that was designed to replace flash memory and, ultimately, DRAM memory. Developed by Stanford Ovshinsky, reknowned for his inventions in memories ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback